Michael Birrer

10.8k total citations
9 papers, 159 citations indexed

About

Michael Birrer is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Michael Birrer has authored 9 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Reproductive Medicine. Recurrent topics in Michael Birrer's work include Ovarian cancer diagnosis and treatment (3 papers), Cell death mechanisms and regulation (2 papers) and Cancer-related Molecular Pathways (2 papers). Michael Birrer is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Cell death mechanisms and regulation (2 papers) and Cancer-related Molecular Pathways (2 papers). Michael Birrer collaborates with scholars based in United States, France and Spain. Michael Birrer's co-authors include Melissa P. Johnston, Timothy J. Bos, Barbara A. Murphy, Gila Neta, Yaffa Rubinstein, Charles Vinson, Alfred C. Johnson, Yipeng Wang, Kutbuddin S. Doctor and Zhenyu Jia and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Genome biology.

In The Last Decade

Michael Birrer

8 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Birrer United States 5 101 65 26 18 17 9 159
Sapana Thomas United States 2 112 1.1× 67 1.0× 32 1.2× 22 1.2× 13 0.8× 2 157
Saya H. Ebbesen United States 3 90 0.9× 45 0.7× 23 0.9× 12 0.7× 12 0.7× 3 123
Guoying Miao China 7 150 1.5× 71 1.1× 51 2.0× 14 0.8× 18 1.1× 12 230
Vincent Yeung United States 5 206 2.0× 98 1.5× 41 1.6× 24 1.3× 10 0.6× 14 275
Caroline S. Kim United States 8 142 1.4× 53 0.8× 17 0.7× 15 0.8× 44 2.6× 11 313
Raúl Navaridas Spain 10 111 1.1× 55 0.8× 35 1.3× 8 0.4× 9 0.5× 17 180
Sharon Maguire United States 5 243 2.4× 53 0.8× 31 1.2× 16 0.9× 22 1.3× 7 307
Ana Tufegdžić Vidaković United Kingdom 6 266 2.6× 94 1.4× 59 2.3× 15 0.8× 26 1.5× 8 319
Cecilia Folio United Kingdom 6 289 2.9× 64 1.0× 40 1.5× 21 1.2× 19 1.1× 6 330
Ben Jenkins United Kingdom 4 130 1.3× 52 0.8× 30 1.2× 21 1.2× 5 0.3× 7 172

Countries citing papers authored by Michael Birrer

Since Specialization
Citations

This map shows the geographic impact of Michael Birrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Birrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Birrer more than expected).

Fields of papers citing papers by Michael Birrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Birrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Birrer. The network helps show where Michael Birrer may publish in the future.

Co-authorship network of co-authors of Michael Birrer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Birrer. A scholar is included among the top collaborators of Michael Birrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Birrer. Michael Birrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lorusso, Domenica, Ana Oaknin, Amit M. Oza, et al.. (2024). Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary. Gynecologic Oncology. 191. 249–258. 8 indexed citations
2.
Garg, Amit, Matts Kågedal, Douglas D. Leipold, et al.. (2017). Abstract CT092: Pharmacokinetics of a THIOMABTM antibody drug conjugate (TDC): DMUC4064A in a phase 1 study with platinum-resistant ovarian cancer. Cancer Research. 77(13_Supplement). CT092–CT092. 1 indexed citations
3.
Ledermann, Jonathan A., Kei Fujiwara, I. Vergote, et al.. (2016). PHASE 3 TRIAL OF AVELUMAB (ANTI-PD-L1) IN COMBINATION WITH AND/OR FOLLOWING PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH UNTREATED OVARIAN CANCER. 1 indexed citations
4.
Mor, Gil, James T. Symanowski, Irene Visintin, Michael Birrer, & David C. Ward. (2009). Abstract #LB-244: Six biomarker panel detects early stage ovarian cancer. Cancer Research. 69.
5.
Arora, Shilpi, Yipeng Wang, Zhenyu Jia, et al.. (2008). Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip. Genome biology. 9(11). R166–R166. 38 indexed citations
6.
Leaner, Virna D., Howard Donninger, & Michael Birrer. (2007). Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target. Current Cancer Therapy Reviews. 3(1). 1–6. 7 indexed citations
7.
Bonome, Tomás, Ronald J. Buckanovich, Michael Birrer, & George Coukos. (2004). Expression profiling of ovarian epithelial cancers with intratumoral T cells identifies genes mediating the host immune response: Implications for survival. Journal of Clinical Oncology. 22(14_suppl). 5011–5011. 1 indexed citations
8.
Johnston, Melissa P., et al.. (2000). Alterations in the gene expression profile of MCF-7 breast tumor cells in response to c-Jun. International Journal of Cancer. 88(2). 180–190. 41 indexed citations
9.
Johnson, Alfred C., Barbara A. Murphy, Yaffa Rubinstein, et al.. (2000). Activator Protein-1 Mediates Induced but not Basal Epidermal Growth Factor Receptor Gene Expression. Molecular Medicine. 6(1). 17–27. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sapana Thomas Breakdown of academic impact, for papers by Saya H. Ebbesen Breakdown of academic impact, for papers by Guoying Miao Breakdown of academic impact, for papers by Vincent Yeung Breakdown of academic impact, for papers by Caroline S. Kim Breakdown of academic impact, for papers by Raúl Navaridas Breakdown of academic impact, for papers by Sharon Maguire Breakdown of academic impact, for papers by Ana Tufegdžić Vidaković Breakdown of academic impact, for papers by Cecilia Folio Breakdown of academic impact, for papers by Ben Jenkins
Rankless by CCL
2026